SEOUL, April 4 (Reuters) – Samsung Bioepis Co Ltd, which aims to become a force in the fledgling biosimilar drugs industry, has filed a lawsuit against the originator of the world’s best-selling…
The post Samsung brings in the lawyers for biosimilars push appeared first on NASDAQ.